Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT02636946

Public ClinicalTrials.gov record NCT02636946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the intraocular pressure (IOP)-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in participants with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy (e.g., due to intolerance or nonadherence).

Study identification

NCT ID
NCT02636946
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
144 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 23, 2016
Primary completion
Jan 25, 2021
Completion
Jan 25, 2021
Last update posted
Feb 22, 2022

2016 – 2021

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Eye Center South Dothan Alabama 36301
Arizona Eye Center Chandler Arizona 85224
Walman Eye Center Chandler Arizona 85225
Shasta Eye Medical Group, Inc. Redding California 96002
Wolstan & Goldberg Eye Associates Torrance California 90505
Eye Associates of Colorado Springs Colorado Springs Colorado 80909
West Coast Eye Institute Lecanto Florida 34461
Emory University Eye Center Atlanta Georgia 30322
Coastal Research Associates, LLC Roswell Georgia 30076
The Eye Care Institute Louisville Kentucky 40206
Fraser Eye Center Fraser Michigan 48026
Galanis Cataract and Laser Eye Center St Louis Missouri 63119
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Asheville Eye Associates Asheville North Carolina 28803
James D. Branch MD Winston-Salem North Carolina 27101
Bergstrom Eye Research, LLC Fargo North Dakota 58103
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066
The Cataract & Glaucoma Center El Paso Texas 79902
DCT- Shah Research Mission Texas 78572
San Antonio Eye Center San Antonio Texas 78215
Vistar Eye Center Roanoke Virginia 24016

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02636946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2022 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02636946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →